FTC and DOJ Hold Second Listening Session on Ways to Make Prescription Drugs More Affordable; Focuses on PBM and Patent Reform

FTC and DOJ Hold Second Listening Session on Ways to Make Prescription Drugs More Affordable; Focuses on PBM and Patent Reform

Pursuant to President Trump’s executive order on Lowering Drug Prices by Once Again Putting Americans First, today, the Federal Trade Commission (FTC), along with the Departments of Justice (DOJ), Health and Human Services (HHS), and Commerce, convened its second of three listing sessions on ways to make prescription drugs more affordable. While the first session (Impact summary) focused primarily on… (Slifer, July 24, 2025) #Drug Pricing, #Food and Drug Administration, #Generic Drugs, #Pharmacy Benefit Managers, #Prescription Drugs